Author

Ömer Komaç

Observed name: Omer Komac

Institution: Adnan Menderes University

Observed institutions: Dokuz Eylül University, Adnan Menderes University

ORCID: 0000-0002-5675-2952

Observed ORCID: 0000-0002-5675-2952

OpenAlex ID: A5002285384

Effects of Empagliflozin on Sarcopenia Risk, Body Composition, and Muscle Strength in Type 2 Diabetes: A 24-Week Real-World Observational Study

2025 · Deniz Çetin, Elif Bilgili, et al. · Medicina · 10

C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group

2019 · Ömer Komaç, Göksel Bengi, et al. · World Journal of Gastrointestinal Oncology · 9

A rare condition in Takayasu arteritis: Renal amyloidosis

2023 · Semih Gülle, Ömer Komaç, et al. · Archives of Rheumatology · 2

Predictors of Malignancy and False‐Negative Risk in Large (≥ 3 cm) Thyroid Nodules: Insights From a Single‐Centre Thyroidectomy Cohort

2026 · Ömer Komaç, Elif Bilgili, et al. · Clinical Endocrinology · 1

P390 - ECE_1526 - Predictors of malignancy and false-negative risk in large (≥3 cm) thyroid nodules: insights from a single-center cohort

2026 · Ömer Komaç, Elif Bilgili, et al. · European Journal of Endocrinology

Syndactyly in Maturity-onset Diabetes of the Young Type 5 (MODY 5): Expanding the Clinical Phenotype - A Case Report

2026 · Mustafa Unubol, Ayse Iyiyapici Unubol, et al. · Cases

Works count: 6

Citation count: 22

H-index: 2

I10-index: 1